MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0091612
Deka Biologics Private Limited
Deka Biologics Private Limited - business outsourcing in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹3.07 Cr
▼ 11% YoY
Net profit · FY 2024
₹4.75 Lakh
Net margin 1.5%
EBITDA · FY 2024
₹8.87 Lakh
EBITDA margin 2.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹46 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
5
As per MCA filings
About Deka Biologics Private Limited
Data last updated:
Deka Biologics Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 01 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2019PTC323455. Its GSTIN is 27AAHCD1711F1Z2 (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Manisha Shekhar Deshmukh and Prabha Sanjay Kadam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D/2/106 Vrindavan Dham Chs Gavanpada Road Neelam Nagar Mulund – E, Mumbai, Maharashtra, India – 400081.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.07 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹4.75 Lakh (net margin 1.5%) and EBITDA of ₹8.87 Lakh (EBITDA margin 2.9%).
As per MCA filings, the company has open charges of ₹46 Lakh on record.
Deka Biologics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0091612).
Company details
CIN U74999MH2019PTC323455
Registration Number 323455
Incorporation Date 01 April 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0091612
Key People
Manisha Shekhar Deshmukh Director Prabha Sanjay Kadam Director Shekhar Prabhakar Deshmukh Director Recognitions & Rankings of Deka Biologics
Contact details
Deka Biologics Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD/2/106 Vrindavan Dham Chs Gavanpada Road Neelam Nagar Mulund – E, Mumbai, Maharashtra, India – 400081
- IndustryBusiness Outsourcing, Business & IT Consulting
To see the full contact details of Deka Biologics Private Limited, buy the company report.
Comprehensive company report
Deka Biologics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Deka Biologics is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Deka Biologics Private Limited, buy the company report.
Financials of Deka Biologics Private Limited
FY 2025 filings availableDeka Biologics Private Limited reported revenue of ₹3.07 Cr (down 11% YoY) for FY 2024.
Revenue · FY 2024
₹3.07 Cr ▼ 11%
Net profit · FY 2024
₹4.75 Lakh margin 1.5%
EBITDA · FY 2024
₹8.87 Lakh margin 2.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 11%
EBITDA CAGR growth
1 year
▲ 69%
Revenue fell 11% in the latest year. EBITDA rose 69% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.87 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.75 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Deka Biologics Private Limited, buy the company report.
Board of directors of Deka Biologics Private Limited
Deka Biologics has 5 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manisha Shekhar Deshmukh | Director | 01 Apr 2019 | 7 Years 6 Months | Current |
| Prabha Sanjay Kadam | Director | 06 Oct 2021 | 5 Years 0 Months | Current |
| Shekhar Prabhakar Deshmukh | Director | 13 Jun 2025 | 1 Years 4 Months | Current |
| Sangeeta Nishikesh Ghorpade | Additional Director | 02 Feb 2026 | 0 Years 8 Months | Current |
| Rupali Gurudatta Mojar | Additional Director | 02 Feb 2026 | 0 Years 8 Months | Current |
Auditor
Deka Biologics Private Limited is audited by Abhijit Shetye and Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Abhijit Shetye and Associates | FY 2023 | 153743 |
Shareholding
The shareholding of Deka Biologics Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Deka Biologics Private Limited, buy the company report.
Charges & borrowings
Open charges
₹46 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Jul 2023 | 100754781 | Others | ₹6 Lakh | Open | |
| 25 Mar 2022 | 100573964 | Others | ₹40 Lakh | Open |
To see the full charge records of Deka Biologics Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Deka Biologics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Deka Biologics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Deka Biologics has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCD1711F1Z2 | Maharashtra | Active | 24 Apr 2019 |
To see the full GST registrations and return filing status of Deka Biologics Private Limited, buy the company report.
Recent activity
Deka Biologics Private Limited has 8 board changes on record since 2019: 5 appointments and 3 cessations. The latest: Rupali Gurudatta Mojar was appointed as Additional Director on 02 Feb 2026.
Appointed
Rupali Gurudatta Mojar was appointed as Additional Director.
Appointed
Sangeeta Nishikesh Ghorpade was appointed as Additional Director.
AGM
Deka Biologics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Shekhar Prabhakar Deshmukh was appointed as Director.
Filing
Deka Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 6.00 Lakh with Charge ID 100754781 was registered on 06 Jul 2023.
Charges
A charge with Others of Rs. 40.00 Lakh registered on 25 Mar 2022 with Charge ID 100573964 was modified on 06 Jul 2023.
Ceased
Prabha Sanjay Kadam ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 40.00 Lakh with Charge ID 100573964 was registered on 25 Mar 2022.
Appointed
Prabha Sanjay Kadam was appointed as Director.
Ceased
Sanjay Laxman Kadam ceased to be Director.
Ceased
Bhaktaraj Bharat Pawaskar ceased to be Director.
2 earlier events are in the company report.
Frequently asked questions
Deka Biologics is an active private limited company based in Mumbai, Maharashtra, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 01 April 2019 (7+ years old) and is registered under CIN U74999MH2019PTC323455.
Deka Biologics has 5 current directors:
- Manisha Shekhar Deshmukh - Director
- Prabha Sanjay Kadam - Director
- Shekhar Prabhakar Deshmukh - Director
- Sangeeta Nishikesh Ghorpade - Additional Director
- Rupali Gurudatta Mojar - Additional Director
The latest financial statements of Deka Biologics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Deka Biologics is 27AAHCD1711F1Z2, registered in Maharashtra.
The CIN (Corporate Identification Number) of Deka Biologics is U74999MH2019PTC323455. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Deka Biologics was incorporated on 01 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Rupali Gurudatta Mojar was appointed as Additional Director on 02 Feb 2026. Sangeeta Nishikesh Ghorpade was appointed as Additional Director on 02 Feb 2026. Shekhar Prabhakar Deshmukh was appointed as Director on 13 Jun 2025. Deka Biologics has 8 board changes on record in total.
Yes, Deka Biologics is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0091612).
The registered office of Deka Biologics is at D2106 Vrindavan Dham Chs Gavanpada Road Neelam Nagar Mulund – E, Mumbai, Maharashtra, India – 400081.
Deka Biologics operates in the business outsourcing industry, in the business and IT consulting segment.